“Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s630. https://doi.org/10.25251/ej4zcr36.